Research Options:
Week of Expected Pricing pending
Company Name ANNOVIS BIO, INC
Proposed Ticker ANVS
CUSIP N/A
Business Description A clinical stage, drug platform company addressing neurodegeneration,such as Alzheimer's disease in Down syndrome (AD-DS), Alzheimer's disease (AD) and Parkinson's disease (PD). We have an ongoing Phase 2a proof-of-concept study in AD patients and have planned to commence a second Phase 2a study in PD patients.
Lead Underwriter ThinkEquity, a division of Fordham Financial Management, Inc
Co-Managers N/A
Initial Shares N/A
Revised Initial Shares N/A
Initial Price N/A
Revised Price N/A
Final Price N/A
Final Ticker N/A

 

 
   
  © 2024 ICE Data Services. All rights reserved.